| 摘要 |
The present invention provides an antigen-presenting cell(APC)/tumor cell conjugate, wherein the antigen-presenting cell (APC) is modified by a cytokine gene selected from the group consisting of IL-2, IL-3, IL-4, IL-6, IL-12, IL-18, IFNalpha, IFNbeta, IFNgamma, TNF, TGF, GM-CSF, and the combination thereof. Said conjugate is useful as a tumor vaccine to significantly induce an immunity specifically against the tumor cell. The present invention also provides the method for preparing the conjugate and a pharmaceutical composition containing said conjugate.
|
